US 10662160
Crystalline salts of a plasma kallikrein inhibitor
granted A61KA61K9/0019A61K9/0029
Quick answer
US patent 10662160 (Crystalline salts of a plasma kallikrein inhibitor) held by BioCryst Pharmaceuticals, Inc. expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K9/0019, A61K9/0029, A61K9/0053, A61P